The Strome group's warrant exercises and blocker increase signal incremental conviction but remain within a passive framework. Monitor for any future conversion to a 13D filing, which would indicate activist intent.
Price Chart
Executive Summary
Mark E. Strome and affiliated entities filed an amended Schedule 13G disclosing aggregate beneficial ownership of 644,916 shares (8.50%) of Cue Biopharma as of October 8, 2026. The filing details partial warrant exercises by Strome Mezzanine Fund II in July–August 2026 and an increase in the warrant exercise blocker from 5% to 8.5%, reflecting active position management but no change in passive intent.
Key Financial Metrics
Key Facts
- Mark E. Strome and affiliates collectively own 8.50% of Cue Biopharma common stock as of October 8, 2026.
- Strome Mezzanine Fund II partially exercised warrants for 99,997 shares on July 14, 2026, 99,996 shares on August 5, 2026, and 99,996 shares on August 27, 2026.
- The warrant blocker was adjusted from 5% to 8.5% effective August 15, 2026, allowing additional exercise capacity.
- Remaining exercisable warrants cover 222,839 shares as of the filing date.
- The filing is an amendment to a prior Schedule 13G and certifies passive investment intent under Rule 13d-1(c).
Financial Impact
No direct financial impact; the filing updates beneficial ownership disclosure following warrant exercises and blocker adjustment.
Risk Factors
- Warrant overhang: remaining 222,839 exercisable shares could add ~3% dilution upon exercise.
- Passive certification limits the group's ability to engage in activist activities without converting to a 13D.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001213900-26-107721 |
| Document: 0001213900-26-107721-index-headers.html | 0001213900-26-107721 |
| Document: 0001213900-26-107721-index.html | 0001213900-26-107721 |
| Document: 0001213900-26-107721.txt | 0001213900-26-107721 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | Insider Cluster | $18.67 $16.71 | ▲ +10.50% | ▲ +9.39% | $18.11 (+2.97%) |
Oct 13, 2026 13d ago | 144 | $18.60 $18.67 | ▲ +0.38% | ▲ +0.09% | $18.11 (−2.61%) |
Oct 8, 2026 19d ago | SC 13G/A | $22.33 $27.66 | ▲ +23.87% | ▲ +23.27% | $18.11 (−18.88%) |
Sep 21, 2026 5w ago | 8-K | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.11 (−35.92%) |
Sep 20, 2026 5w ago | Press Release | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.11 (−35.92%) |
Aug 21, 2026 9w ago | EFFECT | $23.98 $23.18 | ▲ +3.34% | ▲ +3.04% | $18.11 (+24.46%) |
Aug 17, 2026 10w ago | Insider Cluster | $25.70 $26.28 | ▼ −2.26% | ▼ −2.05% | $18.11 (+29.51%) |
Aug 14, 2026 10w ago | Press Release | $27.64 $25.70 | ▼ −7.02% | ▼ −6.34% | $18.11 (−34.46%) |
Aug 13, 2026 10w ago | 144 | $34.20 $27.64 | ▼ −19.18% | ▼ −18.71% | $18.11 (−47.03%) |
Jul 9, 2026 15w ago | Press Release | $36.78 $30.92 | ▼ −15.93% | ▼ −15.17% | $18.11 (−50.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers